A1: patient identifier: requested, not available.A2: age or date of birth: requested, not available.A3a: sex: requested, not available.A3b: gender: n/a.A4: weight: requested, not available.A5: ethnicity: requested, not available.A6: race: requested, not available.D4: lot #: requested, unknown.D4: expiration date: unknown, as the involved product lot # was unknown.D4: udi: n/a as this product code is not exported to the us market.D6a: implanted date: device was not implanted.D6b: explanted date: device was not explanted.H4: device manufacture date: unknown, as the involved product lot # was unknown.The actual device was not returned; therefore, an evaluation of the actual device was unable to be conducted.The involved production lot was unknown, regarding the involved product code, review of the manufacturing record and the shipping inspection record of the production lots for the past three years (equivalent to the expiration period) from the date of occurrence was performed, and no anomaly was found.Since the involved production lot was unknown, a search of the complaint file regarding the involved product code for the past three years (equivalent to the expiration period) was performed, and no other similar report from other facilities was found.This product has a structure in which the stent self-expands by turning the thumbwheel (winding up the release wire connected to the sliding part) and pulling the sliding part toward the proximal side.Regarding the stent elongation, the following simulation tests were conducted in the past.In the simulated lower limb blood vessel model, a contralateral approach was taken with factory-retained destination 6fr 45cm, and the distal end of destination was positioned at the iliac.Then, a factory retained misago was inserted to the sfa along our guidewire.Pulling force was applied while the stent was in the middle of being released.As a result, the stent was elongated with wider spaces between the struts.Cause of occurrence/conclusion; based on our past knowledge, it was thought possible that tensile force toward the proximal side was applied to the actual sample while the stent was being released, which resulted in the elongation of stent; however, the cause of occurrence could not be clarified.Relevant instructions for use (ifu) reference: to maintain the position of the delivery catheter while rotating the thumbwheel, grip the delivery catheter by hand at the operator side (proximal) of the intermediate shaft and do not move the delivery catheter at the operator side of the intermediate shaft.·do not pull the delivery system tight during stent deployment.(the stent can become elongated during deployment.Terumo medical products (tmp) (importer) registration no.(b)(4) is submitting this report on behalf of ashitaka factory of terumo corporation (manufacturer) registration no.(b)(4).
|
The user facility reported that the involved misago 8-100 device was placed after a percutaneous old balloon angioplasty (poba), and after that, the stent was found elongated, so post dilation with senri 7-4 was added to finish the procedure.The stent was pulled with tension during alignment before being placed.Though no health hazard to the patient, the stent was elongated and additional treatment with competitor's device was required.The procedure outcome was completed successfully.The event occurred intra-operative.The final patient impact was not harmed.
|